# Progress Note 06 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Albert Einstein (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET012-SYN
- Date: 2026-09-22
- Fictional facility: St. Posthumous Health Center
- Fictional author: Clementine Ward, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Six-month aneurysm surveillance. **S**

## History of present illness

Mr. Einstein returns six months after his first visit for surveillance duplex ultrasound, done in the vascular laboratory this morning. He has had no abdominal, back, flank, or groin pain, fainting, or leg symptoms. He finished the 7 mg nicotine patch this week and has used only an occasional lozenge, and has had no tobacco for nearly six months. His home blood pressure readings average 122/74. He takes amlodipine, losartan, atorvastatin, and aspirin without side effects. He has booked his eye examination and plans to have his influenza and COVID-19 vaccines at the pharmacy next week. He asked for the numbers in full and wanted to know whether anything in today's results changes the plan agreed in April. **S**

| Element | Detail |
|---|---|
| Aneurysm | 5.1 cm by duplex ultrasound today; 5.0 cm six months ago |
| Symptoms | None |
| Tobacco | Tobacco-free nearly six months; nicotine replacement finished |
| Blood pressure | Home average 122/74 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No fainting, chest pain, or leg pain on walking |
| Gastrointestinal | Negative | No abdominal pain |
| Musculoskeletal | Negative | No back or flank pain; no muscle aches |
| Respiratory | Negative | No cough |

4 systems reviewed. **S**

## Current medications

- Amlodipine 5 mg oral tablet, one tablet daily **S**
- Losartan 100 mg oral tablet, one tablet daily **S**
- Atorvastatin 40 mg oral tablet, one tablet daily **S**
- Aspirin 81 mg delayed-release oral tablet, one tablet daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 124/76 mmHg; pulse 66 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 79.8 kg; BMI 27 kg/m². All vital signs are synthetic.

Abdominal aortic diameter, duplex ultrasound: 5.1 cm (high). All results are synthetic.

## Change since baseline

- Abdominal aortic diameter, duplex ultrasound: 5 cm (high) at baseline, 5.1 cm (high) at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; weight 79.8 kg |
| Cardiovascular | Regular rhythm at 66 per minute; blood pressure 124/76 mmHg; femoral, popliteal, and foot pulses normal |
| Abdomen | Pulsatile, non-tender mass above the umbilicus |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Infrarenal abdominal aortic aneurysm under surveillance** (I71.43). 5.1 cm by duplex ultrasound, against 5.0 cm six months ago: a change of 0.1 cm, within the variation between scans and well below the 0.5 cm in six months that would prompt repair. Still below the 5.5 cm threshold and without symptoms. Popliteal arteries normal at 0.8 cm on each side. The shared decision was reviewed with him and the numbers given in full; his preferences are unchanged, and no repair is indicated. **S**
   - Duplex ultrasound in six months.
   - Copy of today's report to vascular surgery; vascular surgery review at one year or sooner if the threshold is reached.
   - Emergency plan and wallet card reviewed.
2. **Essential hypertension** (I10). At target: 124/76 mmHg in the clinic and 122/74 at home. **S**
   - Continue amlodipine 5 mg and losartan 100 mg.
   - Metabolic panel in about four months, six months after the last, by standing order.
3. **Nicotine dependence, pipe tobacco** (F17.290). Tobacco-free for nearly six months; nicotine replacement completed. **S**
   - Stop the lozenges; call the clinic or the quitline for any urge to restart.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Imaging | Aneurysm diameter by duplex ultrasound (CT if views are poor) | Every 6 months at 5.0 to 5.4 cm in men; yearly at 4.0 to 4.9 cm | Completed today | 5.1 cm today, 5.0 cm six months ago: growth 0.1 cm; next scan in six months |
| Imaging | CT angiography for baseline anatomy and repair planning | Once at baseline; again when repair is considered | Up to date | Baseline done; repeat only if repair is considered |
| Examination | Femoral and popliteal arteries for a coexisting aneurysm | Once at diagnosis | Completed today | Popliteal duplex with today's scan: 0.8 cm on each side, no aneurysm |
| Examination | Aneurysm symptoms and tenderness, with the emergency plan reviewed | Every visit | Completed today | No symptoms; non-tender; emergency plan reviewed |
| Referral | Vascular surgery review and shared decision on elective repair | At baseline, then at a threshold change or yearly | Completed today | Thresholds and options reviewed with him today; preferences unchanged; report sent to vascular surgery, with review at one year |
| Examination | Blood pressure, target below 130/80 | Every visit | Completed today | 124/76 mmHg; at target |
| Self-management | Home blood pressure readings | Before each visit while treatment is being adjusted | Completed today | Home average 122/74 |
| Laboratory | Metabolic panel (sodium, potassium, creatinine, eGFR) | 2 to 4 weeks after starting or changing losartan; then every 6 months | Up to date | Normal ten weeks ago; next due in about four months, by standing order |
| Laboratory | Lipid panel | 4 to 12 weeks after starting a statin; then yearly | Up to date | LDL 62 mg/dL ten weeks ago; repeat yearly |
| Laboratory | ALT | Once before a statin; then only with symptoms | Not indicated | No symptoms |
| Laboratory | HbA1c | Yearly | Up to date | 5.6 percent six months ago; due at one year |
| Laboratory | Urine albumin-to-creatinine ratio | Yearly | Up to date | 14 mg/g six months ago; due at one year |
| Medication safety | Statin adherence and muscle symptoms | Every visit | Completed today | Adherent; no muscle aches |
| Medication safety | Low-dose aspirin: indication and bleeding | Every visit while taking it | Completed today | No bleeding or bruising |
| Medication safety | Medication review: avoid fluoroquinolones and anti-inflammatory pain medicines | Every visit | Completed today | No anti-inflammatory or fluoroquinolone use |
| Self-management | Tobacco use and cessation support (5 A's, nicotine replacement) | Every visit | Completed today | Tobacco-free nearly six months; nicotine replacement finished |
| Examination | 12-lead ECG | Baseline with hypertension; repeat as indicated | Up to date | Normal five months ago |
| Examination | Ankle-brachial index | Every 2 to 3 years at 65 or older or with a smoking history | Completed today | Ankle-brachial index with today's scan: 1.04 on the right and 1.02 on the left, normal |
| Examination | Eye examination for hypertensive retinopathy | Yearly | Due | Examination booked for next month |
| Examination | Weight and BMI | Every visit | Completed today | 79.8 kg; BMI 27.0 |

## Goal progress

- Baseline CT angiography and a vascular surgery consultation, with a documented shared decision about repair thresholds, by the four-week visit. Outcome by 2026-04-21: CT angiography two weeks after the first visit; consultation and shared decision at the four-week visit. **S**
- Blood pressure below 130/80 at the clinic and at home by the three-month visit. Outcome by 2026-07-14: 126/76 mmHg in the clinic; home average 124/74 on amlodipine 5 mg and losartan 100 mg. **S**
- LDL cholesterol at least 50 percent lower and below 70 mg/dL by the three-month visit. Outcome by 2026-07-14: LDL 62 mg/dL on atorvastatin 40 mg, down 56 percent from 142. **S**
- Tobacco-free by the three-month visit and still at six months. Outcome by 2026-09-22: No tobacco since the quit date a week after the first visit; nicotine replacement finished at six months. **S**
- Repeat duplex ultrasound at six months and set the next interval by diameter. Outcome by 2026-09-22: 5.1 cm, 0.1 cm more than at baseline; next scan in six months. **S**

## Medication changes

- Stopped: Nicotine 7 mg/24 hour transdermal patch, one patch daily **S**
- Stopped: Nicotine 2 mg lozenge as needed for cravings **S**

## Guideline basis

- The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm (2018), Society for Vascular Surgery (Journal of Vascular Surgery)
- 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease (2022), American College of Cardiology and American Heart Association (Circulation)
- CMID: Clinical Monitoring Intelligence Database, Hypertension and Hyperlipidemia monographs (2026), Aether Forge
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force

## Follow-up

- Metabolic panel in about four months by standing order. Aneurysm surveillance with duplex ultrasound in six months. Vascular surgery review at one year. Annual wellness visit next summer. **S**

